These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8833937)

  • 1. [Level of total plasma carnitine in patients with chronic renal failure in the course of diabetes and other etiologies treated with hemodialysis].
    Gumprecht J; Snit M; Zukowska-Szczechowska E; Grzeszczak W; Moczulski D; Jendryczko A
    Pol Arch Med Wewn; 1995 Nov; 94(5):403-9. PubMed ID: 8833937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of opiate receptor blockade with naloxone on prolactin (PRL) secretion in patients with diabetes type I (IDDM) with chronic renal failure treated with hemodialysis (HD)].
    Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Gumprecht J; Liszka M; Snit M; Gawron J
    Pol Arch Med Wewn; 1996 Aug; 96(2):132-42. PubMed ID: 9122001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of hemodialysis membranes on the plasma insulin level of diabetic patients on maintenance hemodialysis.
    Abe M; Kikuchi F; Kaizu K; Matsumoto K
    Clin Nephrol; 2008 May; 69(5):354-60. PubMed ID: 18538098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma carnitine levels in patients undergoing hemodialysis.
    Reddi AS; Moquete M; Keshav G; DeAngelis B; Frank O; Baker H
    Nephron; 1998 Sep; 80(1):87-8. PubMed ID: 9730713
    [No Abstract]   [Full Text] [Related]  

  • 6. [Does multiple use of a cuprophan dialyser influence levels of chromium and cadmium during hemodialysis in patients with chronic kidney failure?].
    Małecka J; Grzeszczak W; Zukowska-Szczechowska E; Jendryczko A; Baczyński R
    Pol Arch Med Wewn; 1995 Dec; 94(6):482-7. PubMed ID: 8618810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levels of carnitine and homocysteine in plasma of long-term hemodialysis patients with chronic renal failure].
    Kokot F; Chudek J; Łysiak-SzydŁowska W; Domagała B; Adamczak M; Ignacy W; Kania M; Rutkowski B; Szczeklik A; Wiecek A
    Pol Arch Med Wewn; 2001 Dec; 106(6):1131-6. PubMed ID: 12026532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets].
    Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Cichoń R; Szydłowska I
    Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive evaluation of acute immunological changes induced by cuprophane and polysulfone membranes in a patient on chronic hemodialysis.
    Patarca R; Perez G; Gonzalez A; Garcia-Morales RO; Gamble R; Klimas N; Fletcher MA
    Am J Nephrol; 1992; 12(4):274-8. PubMed ID: 1481878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of plasma insulin and C-peptide levels with 3 different high-flux dialyzers in diabetic patients on hemodialysis.
    Abe M; Okada K; Maruyama T; Inoshita A; Ikeda K; Uto E; Kikuchi F; Matsumoto K
    Int J Artif Organs; 2008 Oct; 31(10):898-904. PubMed ID: 19009508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
    Kadiri S; Kehinde Z; Arije A; Salako BL
    Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of hemodialysis on the virgin CD45RA+, CD45RO- and memory CD45RO+, CD45RA- lymphocyte count in patients with chronic renal failure].
    Szydłowska I; Zukowska-Szczechowska E; Grzeszczak W
    Pol Arch Med Wewn; 2000; 103(3-4):169-77. PubMed ID: 11236244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranitidine clearance during hemodialysis with high-flux membrane: comparison of polysulfone and cellulose acetate hemodialyzers.
    Tsuruoka S; Sugimoto KI; Hayasaka T; Saito T; Fujimura A
    Eur J Clin Pharmacol; 2000 Nov; 56(8):581-3. PubMed ID: 11151748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dialysis membranes on lipoprotein profile of serum in haemodialysed patients.
    Kimak E; Solski J; Janicka L; Wojtysiak B; Zagojska M
    Int Urol Nephrol; 1998; 30(6):789-98. PubMed ID: 10195875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C; Heintz B; Sieberth HG
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antioxidants and malondialdehyde during hemodialysis with cellulose diacetate and polysulfone membranes].
    Eiselt J; Racek J; Holecek V; Krejcová I; Opatrný K
    Cas Lek Cesk; 1996 Nov; 135(21):691-4. PubMed ID: 8998818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in hemodialysis patients without arteriovenous fistula: the effect of dialyzer composition.
    Kiykim AA; Horoz M; Ozcan T; Yildiz I; Sari S; Genctoy G
    Ren Fail; 2010; 32(10):1148-52. PubMed ID: 20954973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of repeated use of cuprophane and polysulfone dialyzers during hemodialysis on the count of natural killer cells in blood].
    Liszka M; Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z
    Pol Arch Med Wewn; 1997 Mar; 97(3):224-31. PubMed ID: 9333768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.